Drug target predictions based on heterogeneous graph inference

Pacific Symposium on Biocomputing

Volumn , Issue , 2013, Pages 53-64

  Wang, Wenhui ^a   Yang, Sen ^a   Jing, Li ^a  

^a Case Western Reserve University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTATIONAL METHODS; GRAPHIC METHODS;

COMPUTATIONAL APPROACH; CROSS VALIDATION; DRUG DEVELOPMENT; DRUG-TARGET INTERACTIONS; EXPERIMENTAL METHODS; HETEROGENEOUS GRAPH; INFERENCE METHODS; TARGET PREDICTION;

FORECASTING;

PROTEIN;

ALGORITHM; BINDING SITE; BIOLOGY; COMPUTER GRAPHICS; DRUG DATABASE; DRUG DEVELOPMENT; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PROCEDURES; PROTEIN DATABASE; STATISTICS AND NUMERICAL DATA; ARTICLE; DRUG EFFECT; METHODOLOGY; STATISTICS;

ALGORITHMS; BINDING SITES; COMPUTATIONAL BIOLOGY; COMPUTER GRAPHICS; DATABASES, PHARMACEUTICAL; DATABASES, PROTEIN; DRUG DISCOVERY; HUMANS; PROTEINS;

EID: 84891477327     PISSN: 23356928     EISSN: 23356936     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. P. Imming, et al, Nat Rev Drug Discov. 10, 821 (2006).
2. S. Haggarty, et al, Chem Biol. 5, 383 (2003).
3. A. Hopkins and C. Groom, Nat Rev Drug Discov. 9, 727 (2002).
4. A. Russ and S. Lampel, Drug Discov Today. 23-24, 1607 (2005).
5. S. Zhu, et al, Bioinformatics, suppl 2, ii245 (2005).
6. A. Cheng, et al, Nat Biotechnol, 1, 71 (2007).
7. M. Campillos, et al, Science, 5886, 263 (2008).
8. Y. Yamanishi and M. Araki, et al, Bioinformatics, 13, i232 (2008).
9. Y. Yamanishi, Proceedings of NIPS, 21, 1433 (2008).
10. M. Keiser, et al, Nature, 7270, 175 (2009).
11. K. Bleakley and Y. Yamanishi, Bioinformatics, 18, 2397 (2009).
12. L. Perlman, et al, J Comput Bio, 2, 133 (2011).
13. F. Cheng, et al, PLoS Comput Biol, 5, e1002503 (2012).
14. G. Jeh and J. Widom, KDD, 538 (2002).
15. A. Chiang, and A. Butte, Clin Pharmacol Ther, 5, 507 (2009).
16. A. Gottlieb, et al, Mol Syst Biol, 496, 496 (2011).
17. C. Knox, et al, Nucleic Acids Res, Database issue, 1035 (2011).
18. D. Weininger, Journal of Chemical Information and Modeling, 1, 31 (1988).
19. C. Steinbeck, et al, Curr Pharm Des, 17, 2111 (2006).
20. T. Tanimoto, IBM Internal Report 17th Nov, (1957).
21. Sophic, http://www.sophicalliance.com/documents/sophicdocs/White%20Paper%20Update%201-27-11/The%20Druggable%20Genome012511.pdf, (2012).
22. P. Flicek, et al, Nucleic Acids Res, Database issue, 800 (2011).
23. S. Hunter, et al, Nucleic Acids Res, Database issue, 211 (2009).
24. T. Smith and M. Waterman, J Mol Biol, 1, 195 (1981).
25. A. Hamosh et al., Nucleic Acids Res, 30, 52 (2002).
26. Y. Chen, et al, Bioinformatics, 13, i167 (2011).
27. M. van Driel, et al, Eur J Hum Genet, 5, 535 (2006).
28. V. Oron, et al, PLoS Comput Biol, 1, e1000641 (2010).
29. T. Sing, et al, Bioinformatics, 20, 3940 (2005).
30. N. Hecker, et al, Nucleic Acids Res, Database issue, D1113 (2012).
31. E. Lounkine, et al, Nature, 486, 361 (2012).
32. Tong, et al., Proceedings of ICDM, 613-622 (2005).
33. Chen, et al., PLoS One, 6, e21137 (2011).